z-logo
Premium
Identification of an MLL4‐GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child
Author(s) -
O'Meara Elaine,
Stack Deirdre,
Phelan Susan,
McDonagh Naomi,
Kelly Lorna,
Sciot Raf,
DebiecRychter Maria,
Morris Thomas,
Cochrane Doug,
Sorensen Poul,
O'Sullivan Maureen J.
Publication year - 2014
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.22208
Subject(s) - gene , biology , fusion gene , cancer research , fusion protein , immunohistochemistry , sarcoma , cell , chromosomal translocation , microbiology and biotechnology , genetics , medicine , pathology , immunology , recombinant dna
Undifferentiated spindle cell sarcoma (UDS) is a poorly defined or understood entity, essentially a waste‐basket for cases failing to fulfill criteria for better‐established diagnoses based on combined histology, immunohistochemistry, and tumor genetic assays. We identified a novel chromosomal translocation t(17;19)(p13;q13) in a pediatric UDS and have characterized this alteration to show rearrangement of the MLL4 and GPS2 genes, resulting in an in‐frame fusion gene MLL4‐GPS2 , the expression of which promotes anchorage‐independent growth. MLL4 was previously reported to be similarly rearranged in hepatocellular carcinomas, notably those positive for hepatitis B virus. Isolated reports of individual rearrangements of GPS2 in a prostate carcinoma cell line and in glioblastoma multiforme, each with different partner genes, recently emerged from high‐throughput sequencing studies but have not been further evaluated for biological effect. © 2014 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom